| 000 | 01627 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250510213748.0 | ||
| 264 | 0 | _c19791024 | |
| 008 | 197910s 0 0 eng d | ||
| 022 | _a0025-7125 | ||
| 024 | 7 |
_a10.1016/s0025-7125(16)31670-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalne, D B | |
| 245 | 0 | 0 |
_aThe pathogensis and medical treatment of extrapyramidal disease. _h[electronic resource] |
| 260 |
_bThe Medical clinics of North America _cJul 1979 |
||
| 300 |
_a715-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAthetosis _xphysiopathology |
| 650 | 0 | 4 |
_aBasal Ganglia Diseases _xtherapy |
| 650 | 0 | 4 |
_aCaudate Nucleus _xpathology |
| 650 | 0 | 4 |
_aChorea _xphysiopathology |
| 650 | 0 | 4 |
_aCorpus Striatum _xphysiopathology |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 | _aDopamine Antagonists |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aDystonia _xphysiopathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlutamates _xmetabolism |
| 650 | 0 | 4 |
_aHaloperidol _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHuntington Disease _xmetabolism |
| 650 | 0 | 4 |
_aLevodopa _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMovement Disorders _xetiology |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aTic Disorders _xdrug therapy |
| 650 | 0 | 4 |
_agamma-Aminobutyric Acid _xbiosynthesis |
| 700 | 1 | _aEisler, T | |
| 773 | 0 |
_tThe Medical clinics of North America _gvol. 63 _gno. 4 _gp. 715-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0025-7125(16)31670-4 _zAvailable from publisher's website |
| 999 |
_c154585 _d154585 |
||